CARA VITADAMO: Open Payments
NPI 1184306193 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,172 in 60 payments from 11 companies in 2025. Trend: 2023 $218 · 2024 $556 · 2025 $1,172
Food & beverage: $1,172
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 15 | $377 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $172 |
| Teva Pharmaceuticals USA, Inc. | 11 | $142 |
| Alkermes, Inc. | 4 | $87 |
| E.R. Squibb & Sons, L.L.C. | 4 | $76 |
| Indivior Inc. | 4 | $71 |
| Otsuka America Pharmaceutical, Inc. | 4 | $71 |
| ABBVIE INC. | 4 | $66 |
| Braeburn Inc. | 3 | $52 |
| Janssen Pharmaceuticals, Inc | 2 | $38 |
Products named: HETLIOZ, CAPLYTA, FANAPT, AUSTEDO XR, COBENFY, SUBLOCADE, VRAYLAR, BRIXADI.
Industry payments across NC — which companies pay providers there.
